Association between p53 overexpression, cell proliferation, tumor necrosis and extent of apoptosis in operated pancreatic adenocarcinoma

APMIS

Volumn 105, Issue 10, 1997, Pages 765-772

  Virkajärvi, Nina ^a   Pääkkö, Paavo ^a   Soini, Ylermi ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Apoptosis; Carcinoma; Cell proliferation; Necrosis; p53; Pancreas

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH; TUMOR NECROSIS;

EID: 0030779033     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05082.x     Document Type: Article

References (35)

1. Bardeesy, N., Beckwith, J. B. & Pelletier, J.: Clonal expansion and attenuated apoptosis in Wilm's tumors are associated with p53 gene mutations. Cancer Res. 55: 215-219, 1995.
2. Baretton, G. B., Diebold, J., Christoforis, G. et al.: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 77: 255-264, 1996.
3. DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N. et al.: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am. J. Clin. Pathol. 101: 684-688, 1994.
4. Eerola, A.-K., Törmänen, U., Soini, Y. et al.: Apoptosis is inversely related to tumour necrosis and p53 immunoreactivity in operated small cell lung carcinomas. J. Pathol. 181: 172-177, 1997.
5. Gibson, J. B. & Sobin, L. H.: Histological Typing of Tumours of the Liver, Biliary Tract and Pancreas. International Histological Classification of Tumours No. 20. World Health Organization, Geneva 1978.
6. Greenblatt, M. S., Bennett, W. P., Hollstein, M. et al.: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 55: 4855-5878, 1994.
7. Hall, P. A., Levinson, D. A., Woods, A. L. et al.: Proliferative cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162: 285-294, 1990.
8. Hockenbery, D. M.: Bcl-2 in cancer, development and apoptosis. J. Cell Sci. 18: 51-55, 1994.
9. Hollstein, M., Sidransky, D., Vogelstein, B. et al.: p53 mutations in human cancers. Science 253: 49-53, 1991.
10. Kerr, J. F. R., Winterford, C. M. & Harmon, B. V.: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
11. Klöppel, G., Lingenthal, G., von Bulow, M. & Kern, H. F.: Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinicohistopathological correlation in a series of 75 cases. Histopathology 9: 841-856, 1985.
12. Lane, D. P.: p53, guardian of the genome. Nature 358: 15-16, 1992.
13. Mercer, W. E., Avignolo, C. & Basegra, R.: Role of p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol. Cell Biol. 4: 276-281, 1984.
14. Mercer, W. E., Shields, M. T., Lin, D. et al.: Growth suppression induced by wild-type p53 is accompanied by selective growth regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sci. USA 88: 1958-1962, 1991.
15. Milner, J.: The role of p53 in normal control of cell proliferation. Curr. Opin. Cell Biol. 3: 282-286, 1991.
16. Miyashita, T., Krajewski, S., Krajewski, M. et al.: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
17. Miyashita, T. & Reed, J. C.: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
18. Nigro, J. M., Baker, S. J., Preisinger, A. C. et al.: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989.
19. O'Neill, A. J., Staunton, M. J. & Gaffney, E. F.: Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma. Histopathology 29: 45-50, 1996.
20. Pelosi, G., Zamboni, G., Doglioni, C. et al.: Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am. J. Surg. Pathol. 16: 1215-1225, 1992.
21. Quinlan, D. C., Davidson, A. G., Summers, C. L. et al.: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 52: 4828-4831, 1992.
22. Redston, M. S., Caldas, C., Seymour, A. B. et al.: p53 mutations in pancreatic carcinoma and evidence of common involvement of homopolymer tracts in DNA microdeletions. Cancer Res. 54: 3025-3033, 1994.
23. Reed, J. C.: Bcl-2 and the regulation of pro- grammed cell death. J. Cell Biol. 124: 1-6, 1994.
24. Scarpa, A., Capelli, P., Mukai, K. et al.: Pancreatic adenocarcinoma frequently show p53 gene mutations. Am. J. Pathol. 142: 1534-1543, 1993.
25. Shivji, M. K., Kenny, M. K. & Wood, R. D.: Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69: 367-374, 1992.
26. Soini, Y., Pääkkö, P., Nuorva, K. et al.: p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br. J. Cancer 68: 1029-1035, 1993.
27. Soini, Y., Virkajärvi, N., Lehto, V.-P. et al.: Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer 73: 1025-1030, 1996.
28. Soini, Y. & Pääkkö, P.: Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Hum. Pathol. 27: 1221-1226, 1996.
29. Soini, Y., Pääkkö, P., Nuorva, K. et al.: Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch. A 421: 223-228, 1992.
30. Spiessl, B., Beahrs, O. H., Hermanek, P. et al.: TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. International Union Against Cancer, Third Edition. Springer Verlag, Berlin 1992.
31. Thor, A., Moore, II, D. H., Edgerton, S. M. et al.: Accumulation of p53 tumor suppressor gene proteIn: An independent marker of prognosis in breast cancers. J. Natl. Cancer Inst. 84: 845-855, 1992.
32. Törmänen, U., Eerola, A.-K., Rainio, P. et al.: Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res. 55: 5595-5602, 1995.
33. Weyrer, K., Feichtinger, H., Haun, M. et al.: p53, Ki-ras and DNA ploidy in human pancreatic ductal adenocarcinomas. Lab. Invest. 74: 279-289, 1996.
34. Yamaguchi, K. & Enjoji, M.: Carcinoma of the pancreas: a clinicopathologic study of 96 cases with immunohistochemical observations. Jpn. J. Clin. Oncol. 19: 14-22, 1989.
35. Yonish-Rouach, E., Resnitzky, D., Lotem, J. et al.: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.